|
Greater Boston Chapter
Chapter Homepage
Licensing Executives Society
Boston Chapter
New Trends in Academic Licensing:
the Drive to Translational Vehicles
Wednesday, March 21, 2007
5:30 – 8:30 p.m.
Edwards Angell Palmer & Dodge LLP
Presenters:
Katherine Gordon, Ph.D., Director
of Business Development, Harvard University Office of Technology Development.Dr.
Gordon is a director of business development at Harvard’s OTD which focuses
on industry alliances, commercialization of intellectual property and start-ups. Dr.
Gordon has held this position since June 2004, and through 2005 also directed
business development activities at the Harvard Center for Neurodegeneration and
Repair. Prior to joining Harvard, Dr. Gordon was involved with a number
of entrepreneurial activities with early-stage biomedical companies in the areas
of strategic development and operations/management. Dr. Gordon previously
founded and ran biotechnology company Apollo BioPharmaceutics, a neuroscience
company that developed novel neuroprotective compounds for Alzheimer's disease
and ophthalmic indications that was acquired by MitoKor Corp. Prior to
Apollo/MitoKor, Dr. Gordon was a Director at Genzyme Corporation. Dr. Gordon
received her Ph.D. from Wesleyan University and was a post-doctoral fellow at
Yale University.
Reid J. Leonard, Ph.D., Executive
Director, External Research and Licensing for the Merck Research Laboratories. Dr.
Leonard is responsible for identifying partnering opportunities that fit with
Merck's strategic research and development goals across all therapeutic and technology
areas, with a focus on early-stage opportunities: university technologies, incubator
and start-up companies, and programs within established companies. Dr.
Leonard graduated from Brandeis University with a BA in biology and psychology.
He earned a Ph.D. in biology (neuroscience) from Purdue. Following a postdoctoral
fellowship in molecular pharmacology at Caltech with Profs Norman Davidson and
Henry Lester, Dr. Leonard joined the Merck Research Labs in Rahway, NJ. After
ten years of basic and discovery research in ion channel biology, Dr. Leonard
moved into External Scientific Affairs, where he was responsible for the scientific
evaluation of partnering opportunities in several therapeutic areas, most recently
endocrine/metabolic and cardiovascular diseases. In November 2005, Reid transitioned
to his current role in Boston.
Frances Toneguzzo, Ph.D., Director,
MGH Corporate Sponsored Research & Licensing. Dr.
Toneguzzo is the Director of the MGH Corporate Sponsored Research & Licensing
office which oversees the management and licensing of intellectual property and
serves as the entry point for all industrial relationships relating to research,
support of research or technology transfer at Massachusetts General Hospital. Prior
to joining MGH, Dr. Toneguzzo served as Director of the Office for Technology
and Industry Collaboration at Tufts University/New England Medical Center and
as Associate Director, responsible for intellectual property relating to the
life sciences at Harvard University. Dr. Toneguzzo comes from the biotech
industry, having played various technical and business development roles at big
pharma (E. I Dupont & Co) as well as mid-sized (E.G.&G.Biomolecular)
and startup companies (One Cell Systems). Dr. Toneguzzo holds a Ph.D.
in Biochemistry from McMaster University in Canada.
Wednesday,
March 21, 2007
5:30 p.m. – 7:00 p.m. – Networking Reception
7:00 p.m. – 8:30 p.m. – Presentation
Edwards Angell Palmer & Dodge LLP
111 Huntington Avenue
Boston, MA 02199-7613
617-239-0100
Edwards Angell Palmer & Dodge LLP is accessible from the
Prudential T Stop on the Green Line
Directions available at: http://www.eapdlaw.com/offices/office.aspx?office=1
Registration:
The cost is $25.00 per attendee. Please register by March 20, 2007.
Online: at http://www.usa-canada.les.org/registration.asp?ID=312
By Check: Make checks payable to "LES Boston"
and return this invitation and the registration fee to:
Carolyn Sullivan Bektas
Boston Chapter Chairperson, Licensing Executives Society
WilmerHale
60 State Street
Boston, MA 02109
Telephone: 617-526-6426 Facsimile: 617-526-5000
e-mail: carolyn.bektas@wilmerhale.com
|
